Literature DB >> 20656361

Differential levels of mRNA transcripts encoding immunologic mediators in mammary gland secretions from dairy cows with subclinical environmental Streptococci infections.

Daniela R Bruno1, Paul V Rossitto, Ralph G S Bruno, Myra T Blanchard, Tatjana Sitt, Bret V Yeargan, Wayne L Smith, James S Cullor, Jeffrey L Stott.   

Abstract

Dry-off, and the period around parturition, are associated with increased susceptibility to intramammary infections in dairy cows. The immunological profiles of mammary gland secretions during these periods are not well described. The objective of the present study was to better characterize association(s) between chronic subclinical Environmental Streptococci infections at dry-off and relative levels of mRNA transcripts encoding multiple immunologic mediators present in cells derived from mammary gland secretions at dry-off and continuing through parturition. The chronic subclinical bacterial infections in the present study were characterized by multiple isolations of Streptococcus species and elevated SSC for a minimum of three weeks prior to dry-off. The majority of differences between principal and control quarters were identified at dry-off. Transcript levels of IL-17, IL2Rα and iNOS were increased while pro-inflammatory cytokine IL-6, and the regulatory cytokine IL-10, were reduced. Following antibiotic treatment of mammary glands, IL-17 transcripts remained elevated over the course of the study, indicative of a persistent insult. IL-4 transcript levels were modestly elevated at 7 days following dry-off and significantly elevated at 14 days, consistent with activated T(H)1 and T(H)2 lymphocytes in the principal quarters, respectively. From a temporal perspective, transcript levels of IL-8 decreased in all animals through the dry-off period animals and returned to pre-dry-off levels at parturition; levels of iNOS peaked at parturition. Five of the six principal cows experienced recurrent bacterial mastitis during the subsequent lactation; four were in the same quarter as was initially infected with Streptococcus and three of these four were due to coliforms. Taken together, this apparent chronic susceptibility of select mammary glands to bacterial infection would suggest a physiologic and/or immunologic dysfunction. Identification of factor(s) that contribute to the predisposition of mammary glands to developing mastitis should facilitate development of new control strategies.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20656361     DOI: 10.1016/j.vetimm.2010.06.009

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  5 in total

1.  Temporal changes in circulating levels of plasma interleukin-8 during peripartum period in Murrah buffaloes (Bubalus bubalis) under subtropical climate.

Authors:  Vijay Kumar; Parveen Kumar; Krishna Mohan; Mihir Sarkar; K P Suresh; M S Chauhan; B S Prakash
Journal:  Trop Anim Health Prod       Date:  2010-11-24       Impact factor: 1.559

2.  Antigen-Specific Mammary Inflammation Depends on the Production of IL-17A and IFN-γ by Bovine CD4+ T Lymphocytes.

Authors:  Pascal Rainard; Patricia Cunha; Marion Ledresseur; Christophe Staub; Jean-Luc Touzé; Florent Kempf; Florence B Gilbert; Gilles Foucras
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

3.  Innate and Adaptive Immunity Synergize to Trigger Inflammation in the Mammary Gland.

Authors:  Pascal Rainard; Patricia Cunha; Florence B Gilbert
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

Review 4.  Progress towards the Elusive Mastitis Vaccines.

Authors:  Pascal Rainard; Florence B Gilbert; Rodrigo P Martins; Pierre Germon; Gilles Foucras
Journal:  Vaccines (Basel)       Date:  2022-02-15

5.  Type 3 immunity: a perspective for the defense of the mammary gland against infections.

Authors:  Pascal Rainard; Patricia Cunha; Rodrigo P Martins; Florence B Gilbert; Pierre Germon; Gilles Foucras
Journal:  Vet Res       Date:  2020-10-15       Impact factor: 3.683

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.